Medulloblastoma Latest Advances

Hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion in a childhood cancer survivor ‒ The role of oral urea in treatment

Journal: Nutricion hospitalaria

Published: September 07, 2026

Medulloblastoma Forms Symbiotic Metabolic Partnerships with Macrophages to Establish Leptomeningeal Metastases.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Molecular Classification and Treatment of Medulloblastoma: An Update

Journal: No shinkei geka. Neurological surgery

Published: August 16, 2026

Central nervous system aspergillosis in a child with medulloblastoma.

Journal: BMJ case reports

Published: August 05, 2026

EXPRESSION OF CONCERN: Cross-Talk Between T-Ag Presence and pRb Family and p53/p73 Signaling in Mouse and Human Medulloblastoma.

Journal: Journal of cellular biochemistry

Published: July 29, 2026

NRF2 activation is required for chemotherapy resistance acquisition in medulloblastoma via metabolic and redox adaptation.

Journal: Redox biology

Published: July 29, 2026

RCBTB2 in cancer: context-dependent functions and translational boundaries.

Journal: Frontiers in oncology

Published: July 24, 2026

Pediatric Brain Tumors.

Journal: Advances in pediatrics

Published: July 21, 2026

Central sleep apnea in pediatric medulloblastoma: A case report.

Journal: Cranio : the journal of craniomandibular practice

Published: July 20, 2026

PTCH1-Related Gorlin Syndrome: Expanding the Clinical and Molecular Spectrum in a Cohort of 11 Patients.

Journal: Klinische Padiatrie

Published: July 16, 2026

Ang2 and TAT targeting of leptomeningeal disease by the intravenous and intrathecal routes: a comparative analysis.

Journal: bioRxiv : the preprint server for biology

Published: July 10, 2026

Ang2 and TAT targeting of leptomeningeal disease by the intravenous and intrathecal routes: a comparative analysis.

Journal: bioRxiv : the preprint server for biology

Published: July 10, 2026

Medulloblastoma Latest Advances

Find the Latest Research About Medulloblastoma

Hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion in a childhood cancer survivor ‒ The role of oral urea in treatment

Hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion in a childhood cancer survivor ‒ The role of oral urea in treatment

Medulloblastoma Forms Symbiotic Metabolic Partnerships with Macrophages to Establish Leptomeningeal Metastases.

Medulloblastoma Forms Symbiotic Metabolic Partnerships with Macrophages to Establish Leptomeningeal Metastases.

Molecular Classification and Treatment of Medulloblastoma: An Update

Molecular Classification and Treatment of Medulloblastoma: An Update

Central nervous system aspergillosis in a child with medulloblastoma.

Central nervous system aspergillosis in a child with medulloblastoma.

EXPRESSION OF CONCERN: Cross-Talk Between T-Ag Presence and pRb Family and p53/p73 Signaling in Mouse and Human Medulloblastoma.

EXPRESSION OF CONCERN: Cross-Talk Between T-Ag Presence and pRb Family and p53/p73 Signaling in Mouse and Human Medulloblastoma.

NRF2 activation is required for chemotherapy resistance acquisition in medulloblastoma via metabolic and redox adaptation.

NRF2 activation is required for chemotherapy resistance acquisition in medulloblastoma via metabolic and redox adaptation.

RCBTB2 in cancer: context-dependent functions and translational boundaries.

RCBTB2 in cancer: context-dependent functions and translational boundaries.

Pediatric Brain Tumors.

Pediatric Brain Tumors.

Central sleep apnea in pediatric medulloblastoma: A case report.

Central sleep apnea in pediatric medulloblastoma: A case report.

PTCH1-Related Gorlin Syndrome: Expanding the Clinical and Molecular Spectrum in a Cohort of 11 Patients.

PTCH1-Related Gorlin Syndrome: Expanding the Clinical and Molecular Spectrum in a Cohort of 11 Patients.

Ang2 and TAT targeting of leptomeningeal disease by the intravenous and intrathecal routes: a comparative analysis.

Ang2 and TAT targeting of leptomeningeal disease by the intravenous and intrathecal routes: a comparative analysis.

Ang2 and TAT targeting of leptomeningeal disease by the intravenous and intrathecal routes: a comparative analysis.

Ang2 and TAT targeting of leptomeningeal disease by the intravenous and intrathecal routes: a comparative analysis.